Literature DB >> 9466577

Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.

M E Gerritsen1, C P Shen, C A Perry.   

Abstract

The activation of sphingomyelinase and the generation of ceramide has been proposed to mediate tumor necrosis factor-alpha (TNF-alpha)-induced nuclear factor (NF)-kappaB activation through its second messenger ceramide. Ceramide may also be an important regulator of cell growth, senescence, and apoptosis. Aberrant cell proliferation and apoptosis have been implicated in the rampant fibroblast proliferation and pannus formation characteristic of rheumatoid arthritis. However, the role of TNF-alpha and the sphingomyelinase pathway in the process have not been determined. The objective of this study was to determine whether TNF-alpha activates the sphingomyelin pathway in human synovial fibroblasts (HSF) and the potential role of ceramide in HSF proliferation and apoptosis. Cultured human synovial fibroblasts were stimulated with exogenous TNF-alpha, sphingomyelinase, and ceramide. Apoptosis was assessed by cell morphology and annexin V labeling. NF-kappaB and stress kinase pathway activation were determined by immunoblotting techniques. Sphingomyelinase activation was determined by quantitation of sphingomyelin and ceramide radioactivity in [14C]serine-prelabeled HSF cells. The addition of TNF-alpha (50 ng/ml) to HSF did not elicit detectable sphingomyelinase activation. TNF-alpha was shown to activate NF-kappaB (p65 translocation and degradation of IkappaBalpha) and the stress kinase pathway (phosphorylation of ATF-2, p38, and c-jun). In contrast, exogenous ceramide had no effect on these signaling pathways nor did ceramide stimulate the generation of interleukin-6 or interleukin-8. High concentrations of ceramide (> or =25 micromol/L) were cytotoxic, whereas lower concentrations of ceramide inhibited cell cycle progression. Thus, although TNF-alpha stimulates the NF-kappaB and stress kinase pathways in HSF, these effects of TNF-alpha are not associated with sphingomyelinase turnover or induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466577      PMCID: PMC1857954     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein.

Authors:  A W Opipari; M S Boguski; V M Dixit
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

Review 3.  The sphingomyelin cycle and the second messenger function of ceramide.

Authors:  Y A Hannun
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

4.  Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.

Authors:  J M Alvaro-Gracia; N J Zvaifler; G S Firestein
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

5.  Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

Authors:  M Y Kim; C Linardic; L Obeid; Y Hannun
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

6.  TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown.

Authors:  S Schütze; K Potthoff; T Machleidt; D Berkovic; K Wiegmann; M Krönke
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

7.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Lymphoid expression and regulation of A20, an inhibitor of programmed cell death.

Authors:  M Tewari; F W Wolf; M F Seldin; K S O'Shea; V M Dixit; L A Turka
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

9.  Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells.

Authors:  Z Yang; M Costanzo; D W Golde; R N Kolesnick
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

Review 10.  Autoimmune disease. A problem of defective apoptosis.

Authors:  J D Mountz; J Wu; J Cheng; T Zhou
Journal:  Arthritis Rheum       Date:  1994-10
View more
  5 in total

1.  Tumor necrosis factor-alpha induces stress fiber formation through ceramide production: role of sphingosine kinase.

Authors:  A N Hanna; L G Berthiaume; Y Kikuchi; D Begg; S Bourgoin; D N Brindley
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

2.  Classification of osteoarthritis phenotypes by metabolomics analysis.

Authors:  Weidong Zhang; Sergei Likhodii; Yuhua Zhang; Erfan Aref-Eshghi; Patricia E Harper; Edward Randell; Roger Green; Glynn Martin; Andrew Furey; Guang Sun; Proton Rahman; Guangju Zhai
Journal:  BMJ Open       Date:  2014-11-19       Impact factor: 2.692

3.  Tripterygium wilfordii glycosides ameliorates collagen-induced arthritis and aberrant lipid metabolism in rats.

Authors:  Yitian Zhu; Luyun Zhang; Xiafeng Zhang; Dehong Wu; Leiming Chen; Changfeng Hu; Chengping Wen; Jia Zhou
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

4.  Sphingolipids in human synovial fluid--a lipidomic study.

Authors:  Marta Krystyna Kosinska; Gerhard Liebisch; Guenter Lochnit; Jochen Wilhelm; Heiko Klein; Ulrich Kaesser; Gabriele Lasczkowski; Markus Rickert; Gerd Schmitz; Juergen Steinmeyer
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

5.  Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes.

Authors:  Jin Lin; Ye Yu; Xuanwei Wang; Yini Ke; Chuanyin Sun; Lihuan Yue; Guanhua Xu; Bei Xu; Liqin Xu; Heng Cao; Danyi Xu; Nancy Olsen; Weiqian Chen
Journal:  J Immunol Res       Date:  2019-11-14       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.